Novel Pharmacological Treatments for the Prevention of Cardiovascular Events
Novel Pharmacological Treatments for the Prevention of Cardiovascular Events Which agents to use and which patients benefit from the newer interventions? OVERVIEW This webinar focuses on the use of novel pharmacological treatment strategies aimed at improving cardiovascular outcomes in medium to high-risk patients. The focus will be on newer lipid lowering agents and novel antidiabetic […]
Clopidogrel or Ticagrelor: Why, When, for Whom?
Dual antiplatelet therapy (DAPT), consisting of aspirin and a P2Y12 inhibitor, is the cornerstone of the management of acute coronary syndromes. Despite its proven benefits, the choice of P2Y12 inhibitors remains to be debated over the decades because of the differences in efficacy and safety profiles among these agents. In this 60-minute session by the […]
ACC.23/WCC
The American College of Cardiology joins the World Heart Federation to host ACC.23 Together With WCC (ACC.23/WCC) in New Orleans, LA, March 4 – 6, 2023. Learn more and register today: https://accscientificsession.acc.org/
Nebivolol: No limb pain?
Beta-blockers are routinely prescribed often as first-line therapy for various cardiovascular diseases such as coronary heart disease and heart failure. Much of their prescribing relates to the benefits of the newer generation of beta-blockers and greater cardio-selectivity. One of the challenges all clinicians face is to manage the choice of numerous beta-blockers and in particular […]
91st EAS Congress
The 91st EAS (European Atherosclerosis Society) Congress will take place on May 21-24, 2023 in Mannheim, Germany. This well-established scientific event is dedicated to the latest advances in research and clinical practice related to atherosclerosis and cardiovascular disease. The congress features keynote lectures, scientific sessions, and poster presentations by leading experts in the […]
XL Congreso Nacional de Cardiología
On behalf of the Argentine Federation of Cardiology, we are pleased to invite you to participate in the XL National Congress of Cardiology, which will take place from 1-3 June 2023, at the Hotel Cóndor de los Andes in Mendoza, Argentina. We are delighted to announce that this year’s program includes an ISCP-FAC joint session; […]
ESC Congress 2023
Joining forces to protect the heart We are delighted to announce that ESC Congress will welcome you in Amsterdam from 25 to 28 August 2023 and online, around the globe. We will join forces to create the future of cardiology – a future where everything is possible! The spotlight of ESC Congress 2023 will be […]
EuroCVP 2023
EuroCVP 2023 The annual meeting on advances in cardiovascular pharmacotherapy The ESC Working Group on Cardiovascular Pharmacotherapy (ESC WG CVP) is delighted to announce its annual meeting, EuroCVP 2023 – Advances in Cardiovascular Pharmacotherapy which will take place from 2 to 4 November 2023, in Florence, Italy. This event offers an outstanding scientific programme […]
ISCP Annual Scientific Meeting 2023 – Seoul, South Korea
Conrad Seoul 10 Gukjegeumyung-ro Yeouido Yeongdeungpo-gu, Seoul, Korea, Democratic People's Republic ofPlease SAVE THE DATE to attend ISCP 28th Annual Scientific Meeting in 2023, to be held on 23rd-25th November in Seoul, South Republic of Korea. For more information and to register, please visit >> https://iscp2023.org It is our great privilege and pleasure to cordially invite all of you to our upcoming 28th ISCP 2023 Seoul. […]
Decongesting the current diuretic landscape in Heart Failure
We are finally back with the second round of our webinar series A to Z of Cardiovascular Pharmacotherapy. Our first session will be titled "Decongesting the current diuretic landscape in Heart Failure" and will be broadcasted live on Wednesday 6th March 2024 at 12.30 GMT. It will be a 1-hour live webinar covering diuretic selection and […]